chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I'm my case both my Lupus and arthritis were exacerbated after the jabs; I'm my case both my Lupus and arthritis were exacerbated after the jabs; I'm my case both my Lupus and arthritis were exacerbated after the jabs; There have been days were the pain is so intense; I was always a walker but part of my life has been taken away; I could barely get out of bed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: SYSTEMIC LUPUS ERYTHEMATOSUS (medically significant), CONDITION AGGRAVATED (medically significant), ARTHRITIS (non-serious), outcome "unknown" and all described as "I'm my case both my Lupus and arthritis were exacerbated after the jabs"; PAIN (non-serious), outcome "unknown", described as "There have been days were the pain is so intense"; QUALITY OF LIFE DECREASED (non-serious), outcome "unknown", described as "I was always a walker but part of my life has been taken away"; BEDRIDDEN (non-serious), outcome "unknown", described as "I could barely get out of bed". Therapeutic measures were taken as a result of pain.  Clinical course: The patient reported that lost more than a year of life due to adhering to what Pfizer stated and your partnership with our government mandating the jab if they wanted to have a little bit of life. But, Pfizer nor the #, had enough information on those with Lupus and arthritis. It appears that about 50 percent of those with Lupus were effected. And some who did not have Lupus were diagnosed with the disease after vaccination. The patient had both Lupus and arthritis were exacerbated after the jabs. The patient always a walker but part of life has been taken away. There were days that patient could barely get out of bed. There had been days were the pain was so intense that the patient can only lied in bed and pray that the medication and sleeping would take away the pain. The patient believe that if more information was given to our doctors they might have explained the possible reactions to an immune suppressed patient. Everything seemed centered on age. The patient not died but there were many days that cursed Pfizer. The patient believe Pfizer owes individuals like patient compensation for the effects of vaccinations that did not need.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
moderna  COVID-19 Vaccine EUA---hardness and itching at injection site, one week after injection
had the usual reactions; after this shot she was feverish; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had the usual reactions) and PYREXIA (after this shot she was feverish) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had the usual reactions) and PYREXIA (after this shot she was feverish). At the time of the report, VACCINATION COMPLICATION (had the usual reactions) and PYREXIA (after this shot she was feverish) outcome was unknown.            Concomitant drug was not reported. Treatment medication was not reported.   This case was linked to MOD-2021-270577 (Patient Link).
rash on chest & abdomen; fine red rash; t98.6 MD says no other side effects were noted @ present; acting nl; had sl fever 22JAN93 & 23JAN93;
Site of injection with swelling to size of a "one ball", purple in color, warm and tender to touch on 11/01/07 after receiving injection on 10/31/07. 11/2/07: states decrease today. Called MD but couldn't get in.
CHILL; FEVER; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced chill, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chill and fever was not reported. This report was non-serious.
booster shot activated the shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles in 1987).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 17-JUN-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient stated that the booster shot activated the shingles that he/she had in 1987. No more shots for him/her. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible, as no contact, details were available.
Pt was seen in travel clinic on 03/20/06 and had hepatitis vaccine 1st dose. 2nd dose is ordered after a month, but pt showed up after 7 days and inadvertently given the 2nd dose. Pt came today for TETANUS/DIPHTHERIA , and realized the mistake. Pt asymptomatic, evaluated by nurse. No complaints voiced. Notified Nurse Manager, Phamacist. Pt will be here on 04/27/06
Cheeks swelled up; Itchy roof of mouth and throat and ears tried to flare up; Itchy roof of mouth and throat and ears tried to flare up; Rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Cheeks swelled up), THROAT IRRITATION (Itchy roof of mouth and throat and ears tried to flare up), ORAL PRURITUS (Itchy roof of mouth and throat and ears tried to flare up) and RASH (Rash on arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Cheeks swelled up), THROAT IRRITATION (Itchy roof of mouth and throat and ears tried to flare up), ORAL PRURITUS (Itchy roof of mouth and throat and ears tried to flare up) and RASH (Rash on arm). At the time of the report, SWELLING FACE (Cheeks swelled up), THROAT IRRITATION (Itchy roof of mouth and throat and ears tried to flare up), ORAL PRURITUS (Itchy roof of mouth and throat and ears tried to flare up) and RASH (Rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-067735 (Patient Link).
A golf ball size swollen lymph node  in the armpit and then on day two it tripled in size and traversed down the entire axillary area. On day two I also had soreness at site of injection and some pain. It was difficult lifting my arm. My fiancée who was a medic for 30 yrs did research online and found this had been reported during some tests. He agreed to watch it closely and marked border areas to ensure no spreading/growth. We closed my business for 7 days & It cleared up after a week gradually improving each day until resolved...utilized some Motrin to treat duscomfort. FYI I have a mammogram later this week. He us adamant I get this on file as May gave future impact if boosters needed later, as such he is filling this out for me.
Client was vaccinated with 2nd dose Moderna on 3/10. Client showed no signs of adverse reaction at time of vaccination or during post-vax monitoring. On 3/14, client started to notice swelling of face. Client went to receive care and was told that it indicated an allergic response. There was "no throat involvement" according to the client. Client's blood pressure was also elevated during the event (see below). This reporter is unaware of any medications administered in the care of the physician. Client recovered and is feeling better now with no residual symptoms. Client came to the site today to report these occurrences to us.
Patient said she began experiencing some leg pains after the first dose of the Pfizer COVID-19 vaccine. She said she thought it was something that was going to go away but has persisted even after getting the second dose. Rph informed patient to talk to her doctor about this issue.
Received call from ER on 10/8/08 that patient admitted in ER (L) arm of cellulitis. Pt. received flu shot only on (L) arm. Rest of info. can be obtained from lab work.  12/8/08-records received for DOS 10/10-10/12/08-DC DX-left arm cellulitis. Presented with 2 day history of worsening cellulitis in left arm. Day after vaccination crying, left arm swollen with erythema. Vesciles appeared on day of admission with one large vesicle rupturing the day of admssion.
pt diagnosed positive for COVID on 9/14/21; treated with Omnicef, steroids, decadron, supplemental O2; dc'd to home; to ED with increasing dyspnea, poor appetite, and weakness; O2 requirement waxed and waned; respiratory status worsened requiring ICU, intubation with mechanical ventilation; pt experienced cardiac arrest , CPR administered, no ROSC achieved; spoke with daughter who elected to stop CPR, pt died in the hospital
Fever, mayalgias, fatigue, swollen and sore lymph node under right arm pit
Redness, swelling  to right thigh at injection site approximately 1 inch diameter and injection site warm to touch upon assessment today 3/22/21 at 1300. Vaccine administered around 11:30am yesterday 3/21/22. Mother reports fussiness, and throwing up last evening (3/21/22) around bedtime (2000pm) and additionally noted the redness and swelling to right thigh. Mother gave Tylenol PO and reports fussiness improved through the night.   Was encouraged today to continue Tylenol for comfort and try warm compress to decrease swelling.
Sore arm, head ache, back and shoulder ache (within 20 minutes), dizziness, extreme nausea and stomachache, wheezing, chest tightening, skin turning red, hives, itchiness, geographic tongue  (1 hour 10 minutes after injection), mouth sores internal and external, swollen tongue, water weight around 5 pounds (48 hours after injection). Continued dizziness, headache, neck pain, swollen tongue, mouth sores, and continued itchiness as of today's date (06/09/21).
(The child) received a varivax vaccine 08/13/01,she had a break through case 2 weeks ago that mom counted over 200 pox. Other siblings that were vaccinated at the same time also had break through cases, but with just a few pox.  Follow up on 01/22/2003: "Information received is correct."
Patient developed encephalitis. He was admitted to hospital. He receieved LP which showed pleocytosis. Other infectious workup negative.
Syncope post vaccination - pt. hit head on the way down - EMS responded within 10 minutes & pt. stable enough for EMS to release.
This spontaneous report was received from a healthcare worker (also reported as "office manager") and referred to a patient of unknown age, race and gender. On 13-JUl-2016 the patient was inadvertently administered a dose of ROTATEQ (lot # K022990), orally which expired on 26-JUN-2016. This was supported as per stability memo. No adverse effects were reported. Additional information has been requested.
Information has been received from a medical assistant concerning a 15 year old female who on 01-AUG-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast) and on 04-AUG-2008 she received the second dose of GARDASIL vaccine (yeast) (lot no. 0250X). In 2007 the patient experienced pain after her first vaccination. Subsequently, the patient recovered. This is one of several reports received from the same source. Additional information has been requested.
06/02/21 - Moderna vaccine administered  at 3:30pm. Waited 15 mins at the HD without any reported side effects. When driving home, client states she felt dizzy. Developed fatigue around 5pm. At 8pm went to have a bowel movement and large amounts of red blood with small clots passed from rectum. Client states she had to flush 3 times d/ t the amount of blood. No stool passed.  No other episodes reported. Client does state that around 2-3 am she was up to use the restroom and noted small amount of dried blood spots in her undergarment. Client states that she does have a h/o hemorrhoids since the birth of her baby but states this "definitely" was not related. Client reported feeling hot during the night with mild abdominal cramping but states she is to start her menstrual cycle soon. PHN questioned if she felt this was her menstrual cycle and client clearly states the blood was coming from her rectum. No further episodes of passing blood reported and states that she is feeling better today. Client states that she does not have a h/o of blood in stool except on occasion scant amounts from hemorrhoids. PHN encouraged client to report this finding to her PCP as well and that the PHN was going to report this to VAERS. No other s/s of bleeding reported to the PHN.
Shock.  After 8 pm, increasing temperature, shaking chills, sore all over body like influenza pins and needles. Shock - almost called EMS - needed fluids - couldn't drink enough to keep temperature down. Shock - shaking chills.  Runny nose, 100.4 temperature at highest, took acetaminophen (325 mg 1 tablet at 10:30 pm) stabilized extreme up and down temperature.  toes on left foot bending backward, splayed out, physically grabbed toes with hand to force gently downward into normal curvature (too much potassium? like a cramp.   needed fluids)  Felt better by 12 pm, temperature 99.3.
pt recvd vax; swollen, erythema for 72 hrs for rt deltoid & upper arm;
Severe dizziness.  I fainted right after being given the shot.  Then I was disoriented and dizzy for the next 24 hours.  I also fainted again 12 hours after the shot.
Chills, difficulty with breathing, tiredness, fever, swollen lymph nodes, and headache.
Brand=Paxlovid , indication=Treatment of COVID-19; Brand=Paxlovid , indication=Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Nov2021 as dose 3 (booster), single (Lot number: Ff2593) at the age of 63 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (unspecified if ongoing), notes: other medical history: Osteoporosis. Concomitant medication(s) included: ALENDRONATE, start date: 19Apr2022, stop date: 19Apr2022. The following information was reported: COVID-19 (medically significant) with onset 2022, outcome "unknown", DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "Brand=Paxlovid , indication=Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative, notes: Tested negative after treatment; (2022) Positive, notes: subsequently tested positive. Therapeutic measures were taken as a result of covid-19.  Clinical course: Anti viral details: [{product=COVID 19 Treatment, brand=Paxlovid ,Treatment start date=15Apr2022, Treatment stop date=19Apr2022. Indication=Treatment of COVID-19}].  Follow up attempts are completed. No further information is expected.
Could have been given after temprature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 20-Feb-2023 Reporter's comment:  The medical assistant reported that the Shingrix vaccines were exposed to 31.1 F and they could had been given to one or more patients.  The reporter had no idea when or if the vaccines was administered after the temperature excursion.  The reporter consent to follow up via email. Additional supportive information:  The Shingrix vaccines were exposed to 31.1F, which led to Incorrect storage of drug.
Information has been received from a physician concerning a 25 year old female secretary with on medical history or allergies, who on 20-FEB-2007 was vaccinated IM into the left arm with a 0.5 ml dose of HPV. Concomitant therapy included Depo-Provera. On approximately 20-FEB-2007, the patient experienced soreness at injection site. On 21-FEB-2007 for that day only the patient experienced nausea. On the morning of 22-FEB-2007 the patient noticed what looks similar to lymph nodes that are enlarged, tender, and swollen by the wrist of the arm in which the vaccine was administered. Unspecified medical attention was sought. No diagnostic laboratory studies were performed. At the time of this report the patient recovered from all events but had not recovered from soreness at the injection site. No product quality complaint was involved. Additional information has been requested.
During the 15 minute post-vaccination observation window, Patient began reporting dizziness and chest heaviness. She denied SOB, itching, throat irritation, or rash. Denies previous adverse reaction to vaccine or injectible.    Vital signs obtained: BP 112/75 O2 sats 98% on room air Heart rate inconsistent by automatic monitor Apical HR 57 with irregular rhythm   Gen: WDWN Asian female with mild distress CV: irregular heart rate, bradycardic  Resp: CTA bilaterally, no wheezing Skin: pale, no rashes/hives Neuro: awake, alert, oriented x 3   Medcom called, report given, and patient transported via wheelchair to hospital adult ER triage.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 56-year-old female patient who received SHINGRIX (batch number 5544H, expiry date 15th May 2021) for prophylaxis. On 15th January 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 16th January 2019, 1 days after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling, injection site blisters and malaise. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site blisters and malaise were not recovered/not resolved. It was unknown if the reporter considered the injection site pain, injection site swelling, injection site blisters and malaise to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on the left arm.
the day after vaccination has had intermittent fatigue, weakness, incontinence, confusion, depression.  Describes his body as "it feels like wood".  Symptoms had improved in Sept, Oct and November.  Got Moderna booster on 12/3/21 and symptoms have returned and continue.
This patient had a headache 11/14 thru 11/18, urinary incontinence, depth perception problems, and visual blurring.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON  10/06/2021. PATIENT FULLY VACCINATED ON 04/22/2021.
My symptoms began gradually - they were subtle at first. It began with nerve pain that started in my left ankle in April. Gradually, this nerve pain developed into severe sciatica on my left side. The neurological symptoms became severe in June and have persisted ever since. Below are just a few days for examples of my symptoms:  February: no symptoms aside from fatigue, full body chills, and body aches 24 hours after vaccine administration.  Wednesday: 8/18  ? legs achy  ? Twitching  ? Shortness of breath  ? Heart palpitations  ? Shaky  ? Mouth and face numb   ? Taste is different   ? Tingling and pins & needles in arms/legs  ? Fingers numb on and off  ? Dizzy upon standing  ? Nausea   ? Tripping over left leg  Thursday:  ? while driving: left arm and leg tingling  ? Left arm numb  ? Chest pressure  ? Dizziness and tingling  ? Back of my head hurts  ? Taste still altered  ? Tripping over left leg  ? Nerve pain in left ankle  Friday 8/20:  ? peripheral neuropathy   ? Numb and tingly feet  ? Sciatic pain  ? Tripping over legs  ? Blurry and cloudy vision   ? Ears wringing  ? Hands and feet numb  ? Horrible headache  ? Face hurts  Saturday 8/21  ? tingling in arms, legs, hands, feet  ? Neuropathy both feet  ? Shaky vision  ? Pressure at the back of head  ? Pressure headache  ? Twitching in arm and neck   ? Shooting pain back of shoulder when I take a deep breath  ? Sore throat  ? Chest pressure  ? Shooting pains down left leg   ? Feet and legs hurting while walking  ? Dizzy  ? Abdominal pain
Patient called with complaints of getting immunization one day prior at clinic (R) deltoid. Stated arm is red and sore and fingers are swollen. States he understand will have some normal side effect, however states site appears to be infected. Denies any drainage. Arm is warm to touch. Appt made with an avail provider this afternoon as requested for further eval. Prednisone 40 mg every day.
Second dose received in less than 25 days after the first dose.; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received in less than 25 days after the first dose.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received in less than 25 days after the first dose.). On 02-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose received in less than 25 days after the first dose.) had resolved.            No concomitant medications were reported.  No treatment medications were reported.  It was reported that the patient took the second dose of the vaccine at day 24.